1832 Asset Management L.P. lowered its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 40.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,993 shares of the company’s stock after selling 2,001 shares during the period. 1832 Asset Management L.P.’s holdings in IDEXX Laboratories were worth $1,616,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also added to or reduced their stakes in the company. Norges Bank acquired a new stake in shares of IDEXX Laboratories during the fourth quarter worth $512,190,000. International Assets Investment Management LLC boosted its holdings in IDEXX Laboratories by 51,631.3% in the 4th quarter. International Assets Investment Management LLC now owns 547,834 shares of the company’s stock valued at $304,075,000 after purchasing an additional 546,775 shares during the period. Capital Research Global Investors acquired a new position in shares of IDEXX Laboratories during the 4th quarter worth approximately $135,910,000. TD Asset Management Inc increased its holdings in shares of IDEXX Laboratories by 178.8% during the fourth quarter. TD Asset Management Inc now owns 260,008 shares of the company’s stock worth $144,317,000 after purchasing an additional 166,751 shares during the period. Finally, Point72 Asset Management L.P. acquired a new stake in shares of IDEXX Laboratories in the fourth quarter valued at approximately $78,001,000. 87.84% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In related news, Director Bruce L. Claflin sold 200 shares of the stock in a transaction on Friday, May 17th. The stock was sold at an average price of $540.80, for a total value of $108,160.00. Following the completion of the sale, the director now directly owns 161 shares of the company’s stock, valued at approximately $87,068.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.11% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Analysis on IDEXX Laboratories
IDEXX Laboratories Trading Down 0.2 %
IDEXX Laboratories stock traded down $0.97 during trading hours on Friday, hitting $469.71. The stock had a trading volume of 588,415 shares, compared to its average volume of 478,889. The business’s 50 day simple moving average is $493.61 and its 200-day simple moving average is $517.16. The stock has a market cap of $38.79 billion, a price-to-earnings ratio of 45.47, a P/E/G ratio of 3.84 and a beta of 1.32. IDEXX Laboratories, Inc. has a one year low of $372.50 and a one year high of $583.39. The company has a quick ratio of 1.16, a current ratio of 1.57 and a debt-to-equity ratio of 0.40.
IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) last issued its quarterly earnings results on Wednesday, May 1st. The company reported $2.81 EPS for the quarter, topping analysts’ consensus estimates of $2.68 by $0.13. The company had revenue of $964.10 million for the quarter, compared to analyst estimates of $965.43 million. IDEXX Laboratories had a net margin of 23.26% and a return on equity of 63.66%. On average, equities analysts predict that IDEXX Laboratories, Inc. will post 11 EPS for the current fiscal year.
IDEXX Laboratories Company Profile
IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.
Featured Articles
- Five stocks we like better than IDEXX Laboratories
- Energy and Oil Stocks Explained
- Is Crypto Cool Again? What Stocks You Should Be Watching
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Why Call Options Volume for These 2 Stocks Spiked Together
- What Is WallStreetBets and What Stocks Are They Targeting?
- MarketBeat Week in Review – 7/22 – 7/26
Want to see what other hedge funds are holding IDXX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report).
Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.